Head of OBU Pricing & HEOR
Negotiable
Pricing/Access Strategy Develop and execute company-level pricing and access strategies for all on-market brands and new assets, with strategic coverage spanning from early clinical phases (PH1) through post-launch, to ensure effective launch, lifecycle management, and value optimization Actas acentral hub to drive collaboration across China Market Access, Business Units, and Global teams, with a focus on maximizing outcomes in NRDL, VBP, CHI, and tendering processes Providein-depth local market insights and policy analyses to shape and refine both local and global market access strategies, ensuring that corporate objectives are achieved within China's dynamic healthcare landscape HEOR Develop and implement payer evidence strategies by collaborating with R&D, Medical, and Early Commercial teams, oversee health economic research projects to support reimbursement, policy advocacy, hospital access, and promotional initiatives, and provide expert advice on NRDL health economic evaluation rules Engage with external stakeholders and experts to anticipate, understand, and shape the evolution of value assessment methodology, health technology assessment rules, and policy frameworks, ultimately influencing the broader market access decision-making environment. Key stakeholders' management Drive effective engagement and partnership with key stakeholders including government agencies, payer organizations, hospital administrators, policy makers, academic experts, and industry associations to influence the market access environment and support access objectives TeamLeadership&BudgetManagement Buildanddevelop high-performing and diverse team with strong talent pipeline Managebudgetsandoptimizeresourceallocation Ensurecompliancewith all company policies, local regulations, and ethical standards
